USA Gene-based Advanced Therapy Medical Product Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the USA Gene-based Advanced Therapy Medical Product market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Gene-based Advanced Therapy Medical Product market. Detailed analysis of key players, along with key growth strategies adopted by Gene-based Advanced Therapy Medical Product industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • bluebird bio

    • Human Stem Cells Institute

    • Alnylam Pharmaceuticals

    • Spark Therapeutics

    • Orchard Therapeutics

    • Biogen

    • Sunway Biotech

    • Gilead Sciences

    • Novartis

    • Sarepta Therapeutics

    • Akcea Therapeutics

    • SIBIONO

    • AnGes

    • Amgen

    By Type:

    • Viral Gene Delivery System

    • Non-viral Gene Delivery System

    By End-User:

    • Neurological Diseases

    • Cancer

    • Other

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Gene-based Advanced Therapy Medical Product Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Gene-based Advanced Therapy Medical Product Market Size and Growth Rate of Viral Gene Delivery System from 2016 to 2027

      • 1.3.2 USA Gene-based Advanced Therapy Medical Product Market Size and Growth Rate of Non-viral Gene Delivery System from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Gene-based Advanced Therapy Medical Product Market Size and Growth Rate of Neurological Diseases from 2016 to 2027

      • 1.4.2 USA Gene-based Advanced Therapy Medical Product Market Size and Growth Rate of Cancer from 2016 to 2027

      • 1.4.3 USA Gene-based Advanced Therapy Medical Product Market Size and Growth Rate of Other from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Gene-based Advanced Therapy Medical Product Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Gene-based Advanced Therapy Medical Product Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Gene-based Advanced Therapy Medical Product Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Gene-based Advanced Therapy Medical Product Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Gene-based Advanced Therapy Medical Product Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Gene-based Advanced Therapy Medical Product by Major Types

      • 3.4.1 Market Size and Growth Rate of Viral Gene Delivery System

      • 3.4.2 Market Size and Growth Rate of Non-viral Gene Delivery System

    4 Segmentation of Gene-based Advanced Therapy Medical Product Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Gene-based Advanced Therapy Medical Product by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Gene-based Advanced Therapy Medical Product in Neurological Diseases

      • 4.4.2 Market Size and Growth Rate of Gene-based Advanced Therapy Medical Product in Cancer

      • 4.4.3 Market Size and Growth Rate of Gene-based Advanced Therapy Medical Product in Other

    5 Market Analysis by Regions

    • 5.1 USA Gene-based Advanced Therapy Medical Product Production Analysis by Regions

    • 5.2 USA Gene-based Advanced Therapy Medical Product Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Gene-based Advanced Therapy Medical Product Landscape Analysis

    • 6.1 West USA Gene-based Advanced Therapy Medical Product Landscape Analysis by Major Types

    • 6.2 West USA Gene-based Advanced Therapy Medical Product Landscape Analysis by Major End-Users

    7 South USA Gene-based Advanced Therapy Medical Product Landscape Analysis

    • 7.1 South USA Gene-based Advanced Therapy Medical Product Landscape Analysis by Major Types

    • 7.2 South USA Gene-based Advanced Therapy Medical Product Landscape Analysis by Major End-Users

    8 Middle West USA Gene-based Advanced Therapy Medical Product Landscape Analysis

    • 8.1 Middle West USA Gene-based Advanced Therapy Medical Product Landscape Analysis by Major Types

    • 8.2 Middle West USA Gene-based Advanced Therapy Medical Product Landscape Analysis by Major End-Users

    9 Northeast USA Gene-based Advanced Therapy Medical Product Landscape Analysis

    • 9.1 Northeast USA Gene-based Advanced Therapy Medical Product Landscape Analysis by Major Types

    • 9.2 Northeast USA Gene-based Advanced Therapy Medical Product Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 bluebird bio

        • 10.1.1 bluebird bio Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Human Stem Cells Institute

        • 10.2.1 Human Stem Cells Institute Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Alnylam Pharmaceuticals

        • 10.3.1 Alnylam Pharmaceuticals Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Spark Therapeutics

        • 10.4.1 Spark Therapeutics Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Orchard Therapeutics

        • 10.5.1 Orchard Therapeutics Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Biogen

        • 10.6.1 Biogen Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Sunway Biotech

        • 10.7.1 Sunway Biotech Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Gilead Sciences

        • 10.8.1 Gilead Sciences Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Novartis

        • 10.9.1 Novartis Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 Sarepta Therapeutics

        • 10.10.1 Sarepta Therapeutics Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

      • 10.11 Akcea Therapeutics

        • 10.11.1 Akcea Therapeutics Company Profile and Recent Development

        • 10.11.2 Market Performance

        • 10.11.3 Product and Service Introduction

      • 10.12 SIBIONO

        • 10.12.1 SIBIONO Company Profile and Recent Development

        • 10.12.2 Market Performance

        • 10.12.3 Product and Service Introduction

      • 10.13 AnGes

        • 10.13.1 AnGes Company Profile and Recent Development

        • 10.13.2 Market Performance

        • 10.13.3 Product and Service Introduction

      • 10.14 Amgen

        • 10.14.1 Amgen Company Profile and Recent Development

        • 10.14.2 Market Performance

        • 10.14.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Gene-based Advanced Therapy Medical Product Market Size and Growth Rate of Viral Gene Delivery System from 2016 to 2027

    • Figure USA Gene-based Advanced Therapy Medical Product Market Size and Growth Rate of Non-viral Gene Delivery System from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Gene-based Advanced Therapy Medical Product Market Size and Growth Rate of Neurological Diseases from 2016 to 2027

    • Figure USA Gene-based Advanced Therapy Medical Product Market Size and Growth Rate of Cancer from 2016 to 2027

    • Figure USA Gene-based Advanced Therapy Medical Product Market Size and Growth Rate of Other from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Gene-based Advanced Therapy Medical Product Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Gene-based Advanced Therapy Medical Product Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Gene-based Advanced Therapy Medical Product Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Gene-based Advanced Therapy Medical Product Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Gene-based Advanced Therapy Medical Product Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Gene-based Advanced Therapy Medical Product

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Gene-based Advanced Therapy Medical Product by Different Types from 2016 to 2027

    • Table Consumption Share of Gene-based Advanced Therapy Medical Product by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Viral Gene Delivery System

    • Figure Market Size and Growth Rate of Non-viral Gene Delivery System

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Gene-based Advanced Therapy Medical Product by Different End-Users from 2016 to 2027

    • Table Consumption Share of Gene-based Advanced Therapy Medical Product by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Neurological Diseases

    • Figure Market Size and Growth Rate of Cancer

    • Figure Market Size and Growth Rate of Other

    • Table USA Gene-based Advanced Therapy Medical Product Production by Regions

    • Table USA Gene-based Advanced Therapy Medical Product Production Share by Regions

    • Figure USA Gene-based Advanced Therapy Medical Product Production Share by Regions in 2016

    • Figure USA Gene-based Advanced Therapy Medical Product Production Share by Regions in 2021

    • Figure USA Gene-based Advanced Therapy Medical Product Production Share by Regions in 2027

    • Table USA Gene-based Advanced Therapy Medical Product Consumption by Regions

    • Table USA Gene-based Advanced Therapy Medical Product Consumption Share by Regions

    • Figure USA Gene-based Advanced Therapy Medical Product Consumption Share by Regions in 2016

    • Figure USA Gene-based Advanced Therapy Medical Product Consumption Share by Regions in 2021

    • Figure USA Gene-based Advanced Therapy Medical Product Consumption Share by Regions in 2027

    • Table West USA Gene-based Advanced Therapy Medical Product Consumption by Types from 2016 to 2027

    • Table West USA Gene-based Advanced Therapy Medical Product Consumption Share by Types from 2016 to 2027

    • Figure West USA Gene-based Advanced Therapy Medical Product Consumption Share by Types in 2016

    • Figure West USA Gene-based Advanced Therapy Medical Product Consumption Share by Types in 2021

    • Figure West USA Gene-based Advanced Therapy Medical Product Consumption Share by Types in 2027

    • Table West USA Gene-based Advanced Therapy Medical Product Consumption by End-Users from 2016 to 2027

    • Table West USA Gene-based Advanced Therapy Medical Product Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Gene-based Advanced Therapy Medical Product Consumption Share by End-Users in 2016

    • Figure West USA Gene-based Advanced Therapy Medical Product Consumption Share by End-Users in 2021

    • Figure West USA Gene-based Advanced Therapy Medical Product Consumption Share by End-Users in 2027

    • Table South USA Gene-based Advanced Therapy Medical Product Consumption by Types from 2016 to 2027

    • Table South USA Gene-based Advanced Therapy Medical Product Consumption Share by Types from 2016 to 2027

    • Figure South USA Gene-based Advanced Therapy Medical Product Consumption Share by Types in 2016

    • Figure South USA Gene-based Advanced Therapy Medical Product Consumption Share by Types in 2021

    • Figure South USA Gene-based Advanced Therapy Medical Product Consumption Share by Types in 2027

    • Table South USA Gene-based Advanced Therapy Medical Product Consumption by End-Users from 2016 to 2027

    • Table South USA Gene-based Advanced Therapy Medical Product Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Gene-based Advanced Therapy Medical Product Consumption Share by End-Users in 2016

    • Figure South USA Gene-based Advanced Therapy Medical Product Consumption Share by End-Users in 2021

    • Figure South USA Gene-based Advanced Therapy Medical Product Consumption Share by End-Users in 2027

    • Table Middle West USA Gene-based Advanced Therapy Medical Product Consumption by Types from 2016 to 2027

    • Table Middle West USA Gene-based Advanced Therapy Medical Product Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Gene-based Advanced Therapy Medical Product Consumption Share by Types in 2016

    • Figure Middle West USA Gene-based Advanced Therapy Medical Product Consumption Share by Types in 2021

    • Figure Middle West USA Gene-based Advanced Therapy Medical Product Consumption Share by Types in 2027

    • Table Middle West USA Gene-based Advanced Therapy Medical Product Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Gene-based Advanced Therapy Medical Product Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Gene-based Advanced Therapy Medical Product Consumption Share by End-Users in 2016

    • Figure Middle West USA Gene-based Advanced Therapy Medical Product Consumption Share by End-Users in 2021

    • Figure Middle West USA Gene-based Advanced Therapy Medical Product Consumption Share by End-Users in 2027

    • Table Northeast USA Gene-based Advanced Therapy Medical Product Consumption by Types from 2016 to 2027

    • Table Northeast USA Gene-based Advanced Therapy Medical Product Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Gene-based Advanced Therapy Medical Product Consumption Share by Types in 2016

    • Figure Northeast USA Gene-based Advanced Therapy Medical Product Consumption Share by Types in 2021

    • Figure Northeast USA Gene-based Advanced Therapy Medical Product Consumption Share by Types in 2027

    • Table Northeast USA Gene-based Advanced Therapy Medical Product Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Gene-based Advanced Therapy Medical Product Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Gene-based Advanced Therapy Medical Product Consumption Share by End-Users in 2016

    • Figure Northeast USA Gene-based Advanced Therapy Medical Product Consumption Share by End-Users in 2021

    • Figure Northeast USA Gene-based Advanced Therapy Medical Product Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of bluebird bio

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of bluebird bio

    • Figure Sales and Growth Rate Analysis of bluebird bio

    • Figure Revenue and Market Share Analysis of bluebird bio

    • Table Product and Service Introduction of bluebird bio

    • Table Company Profile and Development Status of Human Stem Cells Institute

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Human Stem Cells Institute

    • Figure Sales and Growth Rate Analysis of Human Stem Cells Institute

    • Figure Revenue and Market Share Analysis of Human Stem Cells Institute

    • Table Product and Service Introduction of Human Stem Cells Institute

    • Table Company Profile and Development Status of Alnylam Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alnylam Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Alnylam Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Alnylam Pharmaceuticals

    • Table Product and Service Introduction of Alnylam Pharmaceuticals

    • Table Company Profile and Development Status of Spark Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Spark Therapeutics

    • Figure Sales and Growth Rate Analysis of Spark Therapeutics

    • Figure Revenue and Market Share Analysis of Spark Therapeutics

    • Table Product and Service Introduction of Spark Therapeutics

    • Table Company Profile and Development Status of Orchard Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Orchard Therapeutics

    • Figure Sales and Growth Rate Analysis of Orchard Therapeutics

    • Figure Revenue and Market Share Analysis of Orchard Therapeutics

    • Table Product and Service Introduction of Orchard Therapeutics

    • Table Company Profile and Development Status of Biogen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biogen

    • Figure Sales and Growth Rate Analysis of Biogen

    • Figure Revenue and Market Share Analysis of Biogen

    • Table Product and Service Introduction of Biogen

    • Table Company Profile and Development Status of Sunway Biotech

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sunway Biotech

    • Figure Sales and Growth Rate Analysis of Sunway Biotech

    • Figure Revenue and Market Share Analysis of Sunway Biotech

    • Table Product and Service Introduction of Sunway Biotech

    • Table Company Profile and Development Status of Gilead Sciences

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Gilead Sciences

    • Figure Sales and Growth Rate Analysis of Gilead Sciences

    • Figure Revenue and Market Share Analysis of Gilead Sciences

    • Table Product and Service Introduction of Gilead Sciences

    • Table Company Profile and Development Status of Novartis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

    • Figure Sales and Growth Rate Analysis of Novartis

    • Figure Revenue and Market Share Analysis of Novartis

    • Table Product and Service Introduction of Novartis

    • Table Company Profile and Development Status of Sarepta Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sarepta Therapeutics

    • Figure Sales and Growth Rate Analysis of Sarepta Therapeutics

    • Figure Revenue and Market Share Analysis of Sarepta Therapeutics

    • Table Product and Service Introduction of Sarepta Therapeutics

    • Table Company Profile and Development Status of Akcea Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Akcea Therapeutics

    • Figure Sales and Growth Rate Analysis of Akcea Therapeutics

    • Figure Revenue and Market Share Analysis of Akcea Therapeutics

    • Table Product and Service Introduction of Akcea Therapeutics

    • Table Company Profile and Development Status of SIBIONO

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of SIBIONO

    • Figure Sales and Growth Rate Analysis of SIBIONO

    • Figure Revenue and Market Share Analysis of SIBIONO

    • Table Product and Service Introduction of SIBIONO

    • Table Company Profile and Development Status of AnGes

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AnGes

    • Figure Sales and Growth Rate Analysis of AnGes

    • Figure Revenue and Market Share Analysis of AnGes

    • Table Product and Service Introduction of AnGes

    • Table Company Profile and Development Status of Amgen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen

    • Figure Sales and Growth Rate Analysis of Amgen

    • Figure Revenue and Market Share Analysis of Amgen

    • Table Product and Service Introduction of Amgen


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.